Loading...

PE anti-human CD90 (Thy1) Antibody PE anti-human CD90 (Thy1) Antibody

Pricing & Availability
Clone
5E10 (See other available formats)
Regulatory Status
RUO
Workshop
HCDM listed
Other Names
Thy-1, Thy1
Isotype
Mouse IgG1, κ
Ave. Rating
Submit a Review
Product Citations
publications
5E10_PE_021508
Human erythroleukemic cell line HEL stained with 5E10 PE
  • 5E10_PE_021508
    Human erythroleukemic cell line HEL stained with 5E10 PE
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
328109 25 tests DKK796
Check Availability


Need larger quantities of this item?
Request Bulk Quote
328110 100 tests DKK1735
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD90 is a 25-35 kD GPI-anchored protein, also known as Thy-1. It belongs to the Ig superfamily. Human CD90 is expressed on neuronal cells, a subset of CD34+ cells, a subset of fetal liver cells and fetal thymocytes, fibroblasts, activated endothelial cells, and some leukemia cell lines. CD34+CD90+ cells are primitive hematopoietic stem cells. It has been reported that Thy-1 binds with β2 and β3 integrins and plays bimodal roles in the regulation of cell adhesion and neurite outgrowth, and inhibits hematopoietic stem cells proliferation and differentiation.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Human
Reported Reactivity
African Green, Baboon, Cynomolgus, Pigtailed Macaque, Rhesus, Pig
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
HEL cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone 5E10 recognizes an epitope on Thy-1 independent of its glycosylation, but is abolished under reducing conditions.4 Additional reported (for the relevant formats) applications include: immunohistochemical staining of acetone-fixed frozen sections, immunoprecipitation1, and immunofluorescence3.

Application References
  1. Craig W, et al. 1993. J. Exp. Med. 177:1331. (IP)
  2. Gundlach CW 4th, et al. 2011. Bioconjug. Chem. 22:1706. (Pig Reactivity)
  3. Touboul C, et al. 2013. J. Transl. Med. 11:28. (IF)
  4. Bradley JE, et al. 2013. Lab Invest. 93:365. (Epitope)
  5. Donnenberg VS, et al. 2010. Cytometry B. Clin. Cytom. 5:287. (IHC)
Product Citations
  1. Sonoda S, et al. 2022. STAR Protoc. 3:101386. PubMed
  2. Liu C, et al. 2022. Regen Ther. 21:192. PubMed
  3. Zhou Y, et al. 2020. Cancer Cell. 38(6):818-828.e5. PubMed
  4. Melzer C, et al. 2020. Int J Mol Sci. :21. PubMed
  5. Argüello RJ, et al. 2020. Cell Metab. 32:1063. PubMed
  6. Park J, et al. 2021. Exp Ther Med. 22:808. PubMed
  7. Costa MHG, et al. 2021. Biotechnol J. 16:e2000389. PubMed
  8. Labedz-Maslowska A, et al. 2021. Cells. 10: . PubMed
  9. Ye T, et al. 2023. Bioact Mater. 21:194. PubMed
  10. Liu C, et al. 2022. BMC Oral Health. 22:536. PubMed
  11. Robb KP, et al. 2022. Front Immunol. 13:972095. PubMed
  12. Tevlin R, et al. 2023. Sci Rep. 13:2097. PubMed
  13. Aru B, et al. 2023. Balkan Med J. 40:117. PubMed
  14. Korsunsky I, et al. 2022. Med. 3:481. PubMed
  15. Zhu H, et al. 2022. Cell Transplant. 31:9636897221106996. PubMed
  16. Park J, et al. 2022. Bone Joint Res. 11:777. PubMed
  17. Kawai T, et al. 2015. Clin Cancer Res. 21: 3081 - 3091. PubMed
  18. Loegl J, et al. 2016. Reproduction. 152: 447 - 455. PubMed
  19. Goodnough LH, et al. 2020. JBMR Plus. 4:e10398. PubMed
  20. Lee JK, et al. 2020. Sci Rep. 2.567361111. PubMed
  21. Wei H, et al. 2020. Cell Death Dis. 11:290. PubMed
  22. Yang J, et al. 2022. Cell Discov. 8:92. PubMed
  23. Branco MA, et al. 2020. Methods Mol Biol. . PubMed
  24. Zhang B, et al. 2022. Stem Cells Int. 2022:2236250. PubMed
  25. Adutler-Lieber S, et al. 2013. J Cardiovasc Pharmacol Therap. 18:78. PubMed
  26. Wu S, et al. 2020. Stem Cells Int. 2019:1515040. PubMed
  27. Deng CC, et al. 2021. Nat Commun. 12:3709. PubMed
  28. Manresa MC, et al. 2020. Gastroenterology. 159:1778. PubMed
  29. Ali S, et al. 2018. Purinergic Signal. 14:371. PubMed
  30. Li C, et al. 2016. Cell Res. 10.1038/cr.2016.156. PubMed
  31. Samuelson C, et al. 2021. Exp Hematol. 93:52. PubMed
  32. Peterson CW, et al. 2022. Mol Ther Methods Clin Dev. 24:30. PubMed
  33. Zhang J, et al. 2022. Int J Mol Sci. 23:. PubMed
  34. Santos J, et al. 2013. J Transl Med. 11:18. PubMed
  35. Wang H, et al. 2022. Hum Gene Ther. 33:389. PubMed
  36. Van Egeren D, et al. 2021. Cell Stem Cell. 28(3):514-523.e9. PubMed
  37. Osorio FG et al. 2018. Cell reports. 25(9):2308-2316 . PubMed
  38. Di Stefano B, et al. 2019. Cell Stem Cell. 25:622. PubMed
  39. Ambrosi TH, et al. 2020. Aging Cell. 19:e13164. PubMed
  40. Alexander TB, et al. 2018. Nature. 562:373. PubMed
  41. Ye W, et al. 2022. Regen Ther. 21:477. PubMed
  42. Lance R Thurlow et al. 2018. Journal of cellular biochemistry. 120(6):9213-9229 . PubMed
  43. Morgan R, et al. 2016. PLoS One. 11: 0162008. PubMed
  44. Morris K, et al. 2014. PLoS One. 9:98656. PubMed
  45. Meng Z, et al. 2022. Stem Cell Res Ther. 13:466. PubMed
  46. Lee JK, et al. 2021. Cells. 10:. PubMed
  47. Zhang Q, et al. 2021. Bone Joint Res. 10:226. PubMed
  48. Wang LT, et al. 2020. Cell Rep. 32:108188. PubMed
  49. Rabold K, et al. 2022. Nat Commun. 13:6149. PubMed
  50. Marozin S, et al. 2021. Sci Rep. 11:10933. PubMed
  51. Novak R, et al. 2022. Cell Death Dis. 13:820. PubMed
  52. Labedz-Maslowska A, et al. 2020. Int J Mol Sci. 21:. PubMed
  53. Yasuda T, et al. 2021. Cell Reports. 34(8):108779. PubMed
  54. Sielatycka K, et al. 2017. Stem Cell Rev. 1.079166667. PubMed
  55. Wang W, et al. 2022. Int J Mol Sci. 23:. PubMed
  56. Neveu W, et al. 2015. Am J Physiol Cell Physiol. 309: C616 - C626. PubMed
  57. Wang X, et al. 2021. Inflammation. 44:1815. PubMed
  58. Khan SA, et al. 2021. Cell Reports. 35(11):109233. PubMed
  59. Zhao Y, et al. 2018. Stem Cell Reports. 10:509. PubMed
  60. Di Stefano B, et al. 2018. Nat Methods. 15:732. PubMed
  61. Gupta R, et al. 2020. Cell Stem Cell. 26:527. PubMed
  62. Ainsworth RI, et al. 2022. Nat Commun. 13:6221. PubMed
  63. Ward D, et al. 2016. Haematologica. 101: 286 - 296. PubMed
  64. Bailey AL, et al. 2020. bioRxiv. . PubMed
  65. Rodriguez‐Meira A et al. 2019. Molecular cell. 73(6):1292-1305 . PubMed
  66. Sonoda S, et al. 2022. STAR Protoc. 3:101386. PubMed
  67. Liu C, et al. 2022. Regen Ther. 21:192. PubMed
  68. Zhou Y, et al. 2020. Cancer Cell. 38(6):818-828.e5. PubMed
  69. Melzer C, et al. 2020. Int J Mol Sci. :21. PubMed
  70. Argüello RJ, et al. 2020. Cell Metab. 32:1063. PubMed
  71. Park J, et al. 2021. Exp Ther Med. 22:808. PubMed
  72. Costa MHG, et al. 2021. Biotechnol J. 16:e2000389. PubMed
  73. Labedz-Maslowska A, et al. 2021. Cells. 10: . PubMed
  74. Ye T, et al. 2023. Bioact Mater. 21:194. PubMed
  75. Liu C, et al. 2022. BMC Oral Health. 22:536. PubMed
  76. Robb KP, et al. 2022. Front Immunol. 13:972095. PubMed
  77. Tevlin R, et al. 2023. Sci Rep. 13:2097. PubMed
  78. Aru B, et al. 2023. Balkan Med J. 40:117. PubMed
  79. Korsunsky I, et al. 2022. Med. 3:481. PubMed
  80. Zhu H, et al. 2022. Cell Transplant. 31:9636897221106996. PubMed
  81. Park J, et al. 2022. Bone Joint Res. 11:777. PubMed
  82. Kawai T, et al. 2015. Clin Cancer Res. 21: 3081 - 3091. PubMed
  83. Loegl J, et al. 2016. Reproduction. 152: 447 - 455. PubMed
  84. Goodnough LH, et al. 2020. JBMR Plus. 4:e10398. PubMed
  85. Lee JK, et al. 2020. Sci Rep. 2.567361111. PubMed
  86. Wei H, et al. 2020. Cell Death Dis. 11:290. PubMed
  87. Yang J, et al. 2022. Cell Discov. 8:92. PubMed
  88. Branco MA, et al. 2020. Methods Mol Biol. . PubMed
  89. Zhang B, et al. 2022. Stem Cells Int. 2022:2236250. PubMed
  90. Adutler-Lieber S, et al. 2013. J Cardiovasc Pharmacol Therap. 18:78. PubMed
  91. Wu S, et al. 2020. Stem Cells Int. 2019:1515040. PubMed
  92. Deng CC, et al. 2021. Nat Commun. 12:3709. PubMed
  93. Manresa MC, et al. 2020. Gastroenterology. 159:1778. PubMed
  94. Ali S, et al. 2018. Purinergic Signal. 14:371. PubMed
  95. Li C, et al. 2016. Cell Res. 10.1038/cr.2016.156. PubMed
  96. Samuelson C, et al. 2021. Exp Hematol. 93:52. PubMed
  97. Peterson CW, et al. 2022. Mol Ther Methods Clin Dev. 24:30. PubMed
  98. Zhang J, et al. 2022. Int J Mol Sci. 23:. PubMed
  99. Santos J, et al. 2013. J Transl Med. 11:18. PubMed
  100. Wang H, et al. 2022. Hum Gene Ther. 33:389. PubMed
  101. Van Egeren D, et al. 2021. Cell Stem Cell. 28(3):514-523.e9. PubMed
  102. Osorio FG et al. 2018. Cell reports. 25(9):2308-2316 . PubMed
  103. Di Stefano B, et al. 2019. Cell Stem Cell. 25:622. PubMed
  104. Ambrosi TH, et al. 2020. Aging Cell. 19:e13164. PubMed
  105. Alexander TB, et al. 2018. Nature. 562:373. PubMed
  106. Ye W, et al. 2022. Regen Ther. 21:477. PubMed
  107. Lance R Thurlow et al. 2018. Journal of cellular biochemistry. 120(6):9213-9229 . PubMed
  108. Morgan R, et al. 2016. PLoS One. 11: 0162008. PubMed
  109. Morris K, et al. 2014. PLoS One. 9:98656. PubMed
  110. Meng Z, et al. 2022. Stem Cell Res Ther. 13:466. PubMed
  111. Lee JK, et al. 2021. Cells. 10:. PubMed
  112. Zhang Q, et al. 2021. Bone Joint Res. 10:226. PubMed
  113. Wang LT, et al. 2020. Cell Rep. 32:108188. PubMed
  114. Rabold K, et al. 2022. Nat Commun. 13:6149. PubMed
  115. Marozin S, et al. 2021. Sci Rep. 11:10933. PubMed
  116. Novak R, et al. 2022. Cell Death Dis. 13:820. PubMed
  117. Labedz-Maslowska A, et al. 2020. Int J Mol Sci. 21:. PubMed
  118. Yasuda T, et al. 2021. Cell Reports. 34(8):108779. PubMed
  119. Sielatycka K, et al. 2017. Stem Cell Rev. 1.079166667. PubMed
  120. Wang W, et al. 2022. Int J Mol Sci. 23:. PubMed
  121. Neveu W, et al. 2015. Am J Physiol Cell Physiol. 309: C616 - C626. PubMed
  122. Wang X, et al. 2021. Inflammation. 44:1815. PubMed
  123. Khan SA, et al. 2021. Cell Reports. 35(11):109233. PubMed
  124. Zhao Y, et al. 2018. Stem Cell Reports. 10:509. PubMed
  125. Di Stefano B, et al. 2018. Nat Methods. 15:732. PubMed
  126. Gupta R, et al. 2020. Cell Stem Cell. 26:527. PubMed
  127. Ainsworth RI, et al. 2022. Nat Commun. 13:6221. PubMed
  128. Ward D, et al. 2016. Haematologica. 101: 286 - 296. PubMed
  129. Bailey AL, et al. 2020. bioRxiv. . PubMed
  130. Rodriguez‐Meira A et al. 2019. Molecular cell. 73(6):1292-1305 . PubMed
RRID
AB_893442 (BioLegend Cat. No. 328109)
AB_893433 (BioLegend Cat. No. 328110)

Antigen Details

Structure
25-35 kD glycoprotein, Ig superfamily
Distribution

Subset of CD34+ hematopoietic stem cells, subset of fetal thymocytes, subset of fetal liver cells, fibroblast, activated endothelial cells, neurons and some leukemia cell lines

Function
Regulate hematopoiesis and neural cell growth, cell adhesion
Ligand/Receptor
β3 integrin, β2 integrin
Cell Type
Endothelial cells, Fibroblasts, Hematopoietic stem and progenitors, Leukemia, Mesenchymal Stem Cells, Neurons, Thymocytes
Biology Area
Immunology, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. McKenzie JL, et al. 1981. J. Immunol. 126:843.
2. Avalos AM, et al. 2002. Biol. Res. 35:231.
3. Wetzel A, et al. 2004. J. Immunol. 172:3850.

Gene ID
7070 View all products for this Gene ID
UniProt
View information about CD90 on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD90 Reagents Request Custom Conjugation
Description Clone Applications
PE/Dazzle™ 594 anti-human CD90 (Thy1) 5E10 FC
APC/Cyanine7 anti-human CD90 (Thy1) 5E10 FC
TotalSeq™-A0060 anti-human CD90 (Thy1) 5E10 PG
APC/Fire™ 750 anti-human CD90 (Thy1) 5E10 FC
Brilliant Violet 711™ anti-human CD90 (Thy1) 5E10 FC
Brilliant Violet 785™ anti-human CD90 (Thy1) 5E10 FC
Brilliant Violet 650™ anti-human CD90 (Thy1) 5E10 FC
TotalSeq™-C0060 anti-human CD90 (Thy1) 5E10 PG
TotalSeq™-B0060 anti-human CD90 (Thy1) 5E10 PG
Biotin anti-human CD90 (Thy1) 5E10 FC
FITC anti-human CD90 (Thy1) 5E10 FC
PE anti-human CD90 (Thy1) 5E10 FC
APC anti-human CD90 (Thy1) 5E10 FC
PE/Cyanine7 anti-human CD90 (Thy1) 5E10 FC
Purified anti-human CD90 (Thy1) 5E10 FC,CyTOF®,IHC-F,ICC,IP
PE/Cyanine5 anti-human CD90 (Thy1) 5E10 FC
Alexa Fluor® 647 anti-human CD90 (Thy1) 5E10 FC
PerCP/Cyanine5.5 anti-human CD90 (Thy1) 5E10 FC
Alexa Fluor® 700 anti-human CD90 (Thy1) 5E10 FC
Brilliant Violet 421™ anti-human CD90 (Thy1) 5E10 FC
Brilliant Violet 510™ anti-human CD90 (Thy1) 5E10 FC
Brilliant Violet 605™ anti-human CD90 (Thy1) 5E10 FC
Purified anti-human CD90 (Thy1) (Maxpar® Ready) 5E10 FC,CyTOF®
TotalSeq™-D0060 anti-human CD90 (Thy1) 5E10 PG
Spark Blue™ 574 anti-human CD90 (Thy1) (Flexi-Fluor™) 5E10 FC
Spark Red™ 718 anti-human CD90 (Thy1) (Flexi-Fluor™) 5E10 FC
Spark Blue™ 550 anti-human CD90 (Thy1) (Flexi-Fluor™) 5E10 FC
Spark PLUS UV395™ anti-human CD90 (Thy1) 5E10 FC
Spark YG™ 581 anti-human CD90 (Thy1) (Flexi-Fluor™) 5E10 FC
Spark YG™ 593 anti-human CD90 (Thy1) (Flexi-Fluor™) 5E10 FC
Spark NIR™ 685 anti-human CD90 (Thy1) (Flexi-Fluor™) 5E10 FC
Go To Top Version: 3    Revision Date: 08/04/2014

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
5E10 (See other available formats)
Regulatory Status
RUO
Workshop
HCDM listed
Other Names
Thy-1, Thy1
Isotype
Mouse IgG1, κ
Ave. Rating
Submit a Review
Product Citations
publications
5E10_PE_021508
Human erythroleukemic cell line HEL stained with 5E10 PE
  • 5E10_PE_021508
    Human erythroleukemic cell line HEL stained with 5E10 PE
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
328109 25 tests DKK796
Check Availability


Need larger quantities of this item?
Request Bulk Quote
328110 100 tests DKK1735
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD90 is a 25-35 kD GPI-anchored protein, also known as Thy-1. It belongs to the Ig superfamily. Human CD90 is expressed on neuronal cells, a subset of CD34+ cells, a subset of fetal liver cells and fetal thymocytes, fibroblasts, activated endothelial cells, and some leukemia cell lines. CD34+CD90+ cells are primitive hematopoietic stem cells. It has been reported that Thy-1 binds with β2 and β3 integrins and plays bimodal roles in the regulation of cell adhesion and neurite outgrowth, and inhibits hematopoietic stem cells proliferation and differentiation.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Human
Reported Reactivity
African Green, Baboon, Cynomolgus, Pigtailed Macaque, Rhesus, Pig
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
HEL cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone 5E10 recognizes an epitope on Thy-1 independent of its glycosylation, but is abolished under reducing conditions.4 Additional reported (for the relevant formats) applications include: immunohistochemical staining of acetone-fixed frozen sections, immunoprecipitation1, and immunofluorescence3.

Application References
  1. Craig W, et al. 1993. J. Exp. Med. 177:1331. (IP)
  2. Gundlach CW 4th, et al. 2011. Bioconjug. Chem. 22:1706. (Pig Reactivity)
  3. Touboul C, et al. 2013. J. Transl. Med. 11:28. (IF)
  4. Bradley JE, et al. 2013. Lab Invest. 93:365. (Epitope)
  5. Donnenberg VS, et al. 2010. Cytometry B. Clin. Cytom. 5:287. (IHC)
Product Citations
  1. Sonoda S, et al. 2022. STAR Protoc. 3:101386. PubMed
  2. Liu C, et al. 2022. Regen Ther. 21:192. PubMed
  3. Zhou Y, et al. 2020. Cancer Cell. 38(6):818-828.e5. PubMed
  4. Melzer C, et al. 2020. Int J Mol Sci. :21. PubMed
  5. Argüello RJ, et al. 2020. Cell Metab. 32:1063. PubMed
  6. Park J, et al. 2021. Exp Ther Med. 22:808. PubMed
  7. Costa MHG, et al. 2021. Biotechnol J. 16:e2000389. PubMed
  8. Labedz-Maslowska A, et al. 2021. Cells. 10: . PubMed
  9. Ye T, et al. 2023. Bioact Mater. 21:194. PubMed
  10. Liu C, et al. 2022. BMC Oral Health. 22:536. PubMed
  11. Robb KP, et al. 2022. Front Immunol. 13:972095. PubMed
  12. Tevlin R, et al. 2023. Sci Rep. 13:2097. PubMed
  13. Aru B, et al. 2023. Balkan Med J. 40:117. PubMed
  14. Korsunsky I, et al. 2022. Med. 3:481. PubMed
  15. Zhu H, et al. 2022. Cell Transplant. 31:9636897221106996. PubMed
  16. Park J, et al. 2022. Bone Joint Res. 11:777. PubMed
  17. Kawai T, et al. 2015. Clin Cancer Res. 21: 3081 - 3091. PubMed
  18. Loegl J, et al. 2016. Reproduction. 152: 447 - 455. PubMed
  19. Goodnough LH, et al. 2020. JBMR Plus. 4:e10398. PubMed
  20. Lee JK, et al. 2020. Sci Rep. 2.567361111. PubMed
  21. Wei H, et al. 2020. Cell Death Dis. 11:290. PubMed
  22. Yang J, et al. 2022. Cell Discov. 8:92. PubMed
  23. Branco MA, et al. 2020. Methods Mol Biol. . PubMed
  24. Zhang B, et al. 2022. Stem Cells Int. 2022:2236250. PubMed
  25. Adutler-Lieber S, et al. 2013. J Cardiovasc Pharmacol Therap. 18:78. PubMed
  26. Wu S, et al. 2020. Stem Cells Int. 2019:1515040. PubMed
  27. Deng CC, et al. 2021. Nat Commun. 12:3709. PubMed
  28. Manresa MC, et al. 2020. Gastroenterology. 159:1778. PubMed
  29. Ali S, et al. 2018. Purinergic Signal. 14:371. PubMed
  30. Li C, et al. 2016. Cell Res. 10.1038/cr.2016.156. PubMed
  31. Samuelson C, et al. 2021. Exp Hematol. 93:52. PubMed
  32. Peterson CW, et al. 2022. Mol Ther Methods Clin Dev. 24:30. PubMed
  33. Zhang J, et al. 2022. Int J Mol Sci. 23:. PubMed
  34. Santos J, et al. 2013. J Transl Med. 11:18. PubMed
  35. Wang H, et al. 2022. Hum Gene Ther. 33:389. PubMed
  36. Van Egeren D, et al. 2021. Cell Stem Cell. 28(3):514-523.e9. PubMed
  37. Osorio FG et al. 2018. Cell reports. 25(9):2308-2316 . PubMed
  38. Di Stefano B, et al. 2019. Cell Stem Cell. 25:622. PubMed
  39. Ambrosi TH, et al. 2020. Aging Cell. 19:e13164. PubMed
  40. Alexander TB, et al. 2018. Nature. 562:373. PubMed
  41. Ye W, et al. 2022. Regen Ther. 21:477. PubMed
  42. Lance R Thurlow et al. 2018. Journal of cellular biochemistry. 120(6):9213-9229 . PubMed
  43. Morgan R, et al. 2016. PLoS One. 11: 0162008. PubMed
  44. Morris K, et al. 2014. PLoS One. 9:98656. PubMed
  45. Meng Z, et al. 2022. Stem Cell Res Ther. 13:466. PubMed
  46. Lee JK, et al. 2021. Cells. 10:. PubMed
  47. Zhang Q, et al. 2021. Bone Joint Res. 10:226. PubMed
  48. Wang LT, et al. 2020. Cell Rep. 32:108188. PubMed
  49. Rabold K, et al. 2022. Nat Commun. 13:6149. PubMed
  50. Marozin S, et al. 2021. Sci Rep. 11:10933. PubMed
  51. Novak R, et al. 2022. Cell Death Dis. 13:820. PubMed
  52. Labedz-Maslowska A, et al. 2020. Int J Mol Sci. 21:. PubMed
  53. Yasuda T, et al. 2021. Cell Reports. 34(8):108779. PubMed
  54. Sielatycka K, et al. 2017. Stem Cell Rev. 1.079166667. PubMed
  55. Wang W, et al. 2022. Int J Mol Sci. 23:. PubMed
  56. Neveu W, et al. 2015. Am J Physiol Cell Physiol. 309: C616 - C626. PubMed
  57. Wang X, et al. 2021. Inflammation. 44:1815. PubMed
  58. Khan SA, et al. 2021. Cell Reports. 35(11):109233. PubMed
  59. Zhao Y, et al. 2018. Stem Cell Reports. 10:509. PubMed
  60. Di Stefano B, et al. 2018. Nat Methods. 15:732. PubMed
  61. Gupta R, et al. 2020. Cell Stem Cell. 26:527. PubMed
  62. Ainsworth RI, et al. 2022. Nat Commun. 13:6221. PubMed
  63. Ward D, et al. 2016. Haematologica. 101: 286 - 296. PubMed
  64. Bailey AL, et al. 2020. bioRxiv. . PubMed
  65. Rodriguez‐Meira A et al. 2019. Molecular cell. 73(6):1292-1305 . PubMed
  66. Sonoda S, et al. 2022. STAR Protoc. 3:101386. PubMed
  67. Liu C, et al. 2022. Regen Ther. 21:192. PubMed
  68. Zhou Y, et al. 2020. Cancer Cell. 38(6):818-828.e5. PubMed
  69. Melzer C, et al. 2020. Int J Mol Sci. :21. PubMed
  70. Argüello RJ, et al. 2020. Cell Metab. 32:1063. PubMed
  71. Park J, et al. 2021. Exp Ther Med. 22:808. PubMed
  72. Costa MHG, et al. 2021. Biotechnol J. 16:e2000389. PubMed
  73. Labedz-Maslowska A, et al. 2021. Cells. 10: . PubMed
  74. Ye T, et al. 2023. Bioact Mater. 21:194. PubMed
  75. Liu C, et al. 2022. BMC Oral Health. 22:536. PubMed
  76. Robb KP, et al. 2022. Front Immunol. 13:972095. PubMed
  77. Tevlin R, et al. 2023. Sci Rep. 13:2097. PubMed
  78. Aru B, et al. 2023. Balkan Med J. 40:117. PubMed
  79. Korsunsky I, et al. 2022. Med. 3:481. PubMed
  80. Zhu H, et al. 2022. Cell Transplant. 31:9636897221106996. PubMed
  81. Park J, et al. 2022. Bone Joint Res. 11:777. PubMed
  82. Kawai T, et al. 2015. Clin Cancer Res. 21: 3081 - 3091. PubMed
  83. Loegl J, et al. 2016. Reproduction. 152: 447 - 455. PubMed
  84. Goodnough LH, et al. 2020. JBMR Plus. 4:e10398. PubMed
  85. Lee JK, et al. 2020. Sci Rep. 2.567361111. PubMed
  86. Wei H, et al. 2020. Cell Death Dis. 11:290. PubMed
  87. Yang J, et al. 2022. Cell Discov. 8:92. PubMed
  88. Branco MA, et al. 2020. Methods Mol Biol. . PubMed
  89. Zhang B, et al. 2022. Stem Cells Int. 2022:2236250. PubMed
  90. Adutler-Lieber S, et al. 2013. J Cardiovasc Pharmacol Therap. 18:78. PubMed
  91. Wu S, et al. 2020. Stem Cells Int. 2019:1515040. PubMed
  92. Deng CC, et al. 2021. Nat Commun. 12:3709. PubMed
  93. Manresa MC, et al. 2020. Gastroenterology. 159:1778. PubMed
  94. Ali S, et al. 2018. Purinergic Signal. 14:371. PubMed
  95. Li C, et al. 2016. Cell Res. 10.1038/cr.2016.156. PubMed
  96. Samuelson C, et al. 2021. Exp Hematol. 93:52. PubMed
  97. Peterson CW, et al. 2022. Mol Ther Methods Clin Dev. 24:30. PubMed
  98. Zhang J, et al. 2022. Int J Mol Sci. 23:. PubMed
  99. Santos J, et al. 2013. J Transl Med. 11:18. PubMed
  100. Wang H, et al. 2022. Hum Gene Ther. 33:389. PubMed
  101. Van Egeren D, et al. 2021. Cell Stem Cell. 28(3):514-523.e9. PubMed
  102. Osorio FG et al. 2018. Cell reports. 25(9):2308-2316 . PubMed
  103. Di Stefano B, et al. 2019. Cell Stem Cell. 25:622. PubMed
  104. Ambrosi TH, et al. 2020. Aging Cell. 19:e13164. PubMed
  105. Alexander TB, et al. 2018. Nature. 562:373. PubMed
  106. Ye W, et al. 2022. Regen Ther. 21:477. PubMed
  107. Lance R Thurlow et al. 2018. Journal of cellular biochemistry. 120(6):9213-9229 . PubMed
  108. Morgan R, et al. 2016. PLoS One. 11: 0162008. PubMed
  109. Morris K, et al. 2014. PLoS One. 9:98656. PubMed
  110. Meng Z, et al. 2022. Stem Cell Res Ther. 13:466. PubMed
  111. Lee JK, et al. 2021. Cells. 10:. PubMed
  112. Zhang Q, et al. 2021. Bone Joint Res. 10:226. PubMed
  113. Wang LT, et al. 2020. Cell Rep. 32:108188. PubMed
  114. Rabold K, et al. 2022. Nat Commun. 13:6149. PubMed
  115. Marozin S, et al. 2021. Sci Rep. 11:10933. PubMed
  116. Novak R, et al. 2022. Cell Death Dis. 13:820. PubMed
  117. Labedz-Maslowska A, et al. 2020. Int J Mol Sci. 21:. PubMed
  118. Yasuda T, et al. 2021. Cell Reports. 34(8):108779. PubMed
  119. Sielatycka K, et al. 2017. Stem Cell Rev. 1.079166667. PubMed
  120. Wang W, et al. 2022. Int J Mol Sci. 23:. PubMed
  121. Neveu W, et al. 2015. Am J Physiol Cell Physiol. 309: C616 - C626. PubMed
  122. Wang X, et al. 2021. Inflammation. 44:1815. PubMed
  123. Khan SA, et al. 2021. Cell Reports. 35(11):109233. PubMed
  124. Zhao Y, et al. 2018. Stem Cell Reports. 10:509. PubMed
  125. Di Stefano B, et al. 2018. Nat Methods. 15:732. PubMed
  126. Gupta R, et al. 2020. Cell Stem Cell. 26:527. PubMed
  127. Ainsworth RI, et al. 2022. Nat Commun. 13:6221. PubMed
  128. Ward D, et al. 2016. Haematologica. 101: 286 - 296. PubMed
  129. Bailey AL, et al. 2020. bioRxiv. . PubMed
  130. Rodriguez‐Meira A et al. 2019. Molecular cell. 73(6):1292-1305 . PubMed
RRID
AB_893442 (BioLegend Cat. No. 328109)
AB_893433 (BioLegend Cat. No. 328110)

Antigen Details

Structure
25-35 kD glycoprotein, Ig superfamily
Distribution

Subset of CD34+ hematopoietic stem cells, subset of fetal thymocytes, subset of fetal liver cells, fibroblast, activated endothelial cells, neurons and some leukemia cell lines

Function
Regulate hematopoiesis and neural cell growth, cell adhesion
Ligand/Receptor
β3 integrin, β2 integrin
Cell Type
Endothelial cells, Fibroblasts, Hematopoietic stem and progenitors, Leukemia, Mesenchymal Stem Cells, Neurons, Thymocytes
Biology Area
Immunology, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. McKenzie JL, et al. 1981. J. Immunol. 126:843.
2. Avalos AM, et al. 2002. Biol. Res. 35:231.
3. Wetzel A, et al. 2004. J. Immunol. 172:3850.

Gene ID
7070 View all products for this Gene ID
UniProt
View information about CD90 on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD90 Reagents Request Custom Conjugation
Description Clone Applications
PE/Dazzle™ 594 anti-human CD90 (Thy1) 5E10 FC
APC/Cyanine7 anti-human CD90 (Thy1) 5E10 FC
TotalSeq™-A0060 anti-human CD90 (Thy1) 5E10 PG
APC/Fire™ 750 anti-human CD90 (Thy1) 5E10 FC
Brilliant Violet 711™ anti-human CD90 (Thy1) 5E10 FC
Brilliant Violet 785™ anti-human CD90 (Thy1) 5E10 FC
Brilliant Violet 650™ anti-human CD90 (Thy1) 5E10 FC
TotalSeq™-C0060 anti-human CD90 (Thy1) 5E10 PG
TotalSeq™-B0060 anti-human CD90 (Thy1) 5E10 PG
Biotin anti-human CD90 (Thy1) 5E10 FC
FITC anti-human CD90 (Thy1) 5E10 FC
PE anti-human CD90 (Thy1) 5E10 FC
APC anti-human CD90 (Thy1) 5E10 FC
PE/Cyanine7 anti-human CD90 (Thy1) 5E10 FC
Purified anti-human CD90 (Thy1) 5E10 FC,CyTOF®,IHC-F,ICC,IP
PE/Cyanine5 anti-human CD90 (Thy1) 5E10 FC
Alexa Fluor® 647 anti-human CD90 (Thy1) 5E10 FC
PerCP/Cyanine5.5 anti-human CD90 (Thy1) 5E10 FC
Alexa Fluor® 700 anti-human CD90 (Thy1) 5E10 FC
Brilliant Violet 421™ anti-human CD90 (Thy1) 5E10 FC
Brilliant Violet 510™ anti-human CD90 (Thy1) 5E10 FC
Brilliant Violet 605™ anti-human CD90 (Thy1) 5E10 FC
Purified anti-human CD90 (Thy1) (Maxpar® Ready) 5E10 FC,CyTOF®
TotalSeq™-D0060 anti-human CD90 (Thy1) 5E10 PG
Spark Blue™ 574 anti-human CD90 (Thy1) (Flexi-Fluor™) 5E10 FC
Spark Red™ 718 anti-human CD90 (Thy1) (Flexi-Fluor™) 5E10 FC
Spark Blue™ 550 anti-human CD90 (Thy1) (Flexi-Fluor™) 5E10 FC
Spark PLUS UV395™ anti-human CD90 (Thy1) 5E10 FC
Spark YG™ 581 anti-human CD90 (Thy1) (Flexi-Fluor™) 5E10 FC
Spark YG™ 593 anti-human CD90 (Thy1) (Flexi-Fluor™) 5E10 FC
Spark NIR™ 685 anti-human CD90 (Thy1) (Flexi-Fluor™) 5E10 FC
Go To Top Version: 3    Revision Date: 08/04/2014

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account